AbbVie Inc. closed 15.68% short of its 52-week high of $207.32, which the company achieved on October 31st.

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look ...

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look ...

Tom Lee, Fundstrat Global Advisors managing partner and head of research, appeared on CNBC to talk about his 2025 playbook.

AbbVie Inc . (NYSE:ABBV), a pharmaceutical company, has amended its bylaws, effective September 6, 2024. The changes were approved by the Board of Directors and include an update... NORTH CHICAGO ...

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Vanguard Health Care ETF (VHT), a passively managed exchange traded fund launched on ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including sig ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today ...

Amazon.com stock climbed to a record high on Tuesday, and analysts said investors could expect the good times to keep going in 2025. Shares of the e-commerce company closed 1.2% higher to a record ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...